Wells Fargo’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.7M | Buy |
375,894
+43,174
| +13% | +$1.77M | ﹤0.01% | 1610 |
|
|
2026
Q1 | $11.1M | Sell |
332,720
-62,960
| -16% | -$1.88M | ﹤0.01% | 1955 |
|
|
2025
Q4 | $11.8M | Buy |
395,680
+123,013
| +45% | +$4.02M | ﹤0.01% | 1901 |
|
|
2025
Q3 | $9.85M | Sell |
272,667
-43,922
| -14% | -$1.45M | ﹤0.01% | 2013 |
|
|
2025
Q2 | $11.4M | Buy |
316,589
+23,049
| +8% | +$858K | ﹤0.01% | 1810 |
|
|
2025
Q1 | $11.6M | Sell |
293,540
-37,863
| -11% | -$1.27M | ﹤0.01% | 1744 |
|
|
2024
Q4 | $9.98M | Buy |
331,403
+152,682
| +85% | +$4.38M | ﹤0.01% | 1891 |
|
|
2024
Q3 | $4.18M | Buy |
178,721
+23,047
| +15% | +$503K | ﹤0.01% | 2489 |
|
|
2024
Q2 | $2.77M | Buy |
155,674
+75,851
| +95% | +$1.21M | ﹤0.01% | 2724 |
|
|
2024
Q1 | $1.21M | Buy |
79,823
+15,375
| +24% | +$245K | ﹤0.01% | 3329 |
|
|
2023
Q4 | $1.1M | Sell |
64,448
-146,165
| -69% | -$1.7M | ﹤0.01% | 3381 |
|
|
2023
Q3 | $1.76M | Buy |
210,613
+65,637
| +45% | +$915K | ﹤0.01% | 2902 |
|
|
2023
Q2 | $3.6M | Buy |
144,976
+11,999
| +9% | +$310K | ﹤0.01% | 2408 |
|
|
2023
Q1 | $2M | Buy |
132,977
+104,129
| +361% | +$1.58M | ﹤0.01% | 2857 |
|
|
2022
Q4 | $341K | Sell |
28,848
-6,745
| -19% | -$49K | ﹤0.01% | 3873 |
|
|
2022
Q3 | $211K | Sell |
35,593
-10,853
| -23% | -$71.2K | ﹤0.01% | 4218 |
|
|
2022
Q2 | $198K | Sell |
46,446
-45,215
| -49% | -$282K | ﹤0.01% | 4283 |
|
|
2022
Q1 | $872K | Sell |
91,661
-50,150
| -35% | -$580K | ﹤0.01% | 4007 |
|
|
2021
Q4 | $2.69M | Buy |
141,811
+47,609
| +51% | +$1.24M | ﹤0.01% | 3199 |
|
|
2021
Q3 | $3.14M | Buy |
94,202
+26,294
| +39% | +$813K | ﹤0.01% | 3273 |
|
|
2021
Q2 | $2.63M | Sell |
67,908
-53,174
| -44% | -$2.09M | ﹤0.01% | 3440 |
|
|
2021
Q1 | $5.84M | Sell |
121,082
-40,330
| -25% | -$1.94M | ﹤0.01% | 2700 |
|
|
2020
Q4 | $8.4M | Buy |
161,412
+28,429
| +21% | +$960K | ﹤0.01% | 2241 |
|
|
2020
Q3 | $3.56M | Buy |
132,983
+4,221
| +3% | +$97.1K | ﹤0.01% | 2825 |
|
|
2020
Q2 | $2.51M | Buy |
128,762
+67,547
| +110% | +$1.09M | ﹤0.01% | 3100 |
|
|
2020
Q1 | $602K | Sell |
61,215
-45,485
| -43% | -$574K | ﹤0.01% | 3904 |
|
|
2019
Q4 | $1.19M | Buy |
106,700
+29,630
| +38% | +$225K | ﹤0.01% | 3742 |
|
|
2019
Q3 | $434K | Buy |
77,070
+20,739
| +37% | +$145K | ﹤0.01% | 4475 |
|
|
2019
Q2 | $487K | Sell |
56,331
-16,080
| -22% | -$122K | ﹤0.01% | 4396 |
|
|
2019
Q1 | $582K | Sell |
72,411
-3,889
| -5% | -$21K | ﹤0.01% | 4238 |
|
|
2018
Q4 | $313K | Buy |
76,300
+32,254
| +73% | +$160K | ﹤0.01% | 4640 |
|
|
2018
Q3 | $248K | Sell |
44,046
-844,722
| -95% | -$9.65M | ﹤0.01% | 4884 |
|
|
2018
Q2 | $11.7M | Buy |
888,768
+849,233
| +2,148% | +$11.7M | ﹤0.01% | 1949 |
|
|
2018
Q1 | $562K | Buy |
39,535
+4,460
| +13% | +$57K | ﹤0.01% | 4312 |
|
|
2017
Q4 | $287K | Sell |
35,075
-19,066
| -35% | -$167K | ﹤0.01% | 4780 |
|
|
2017
Q3 | $642K | Sell |
54,141
-781
| -1% | -$8.9K | ﹤0.01% | 4163 |
|
|
2017
Q2 | $552K | Sell |
54,922
-607
| -1% | -$6.79K | ﹤0.01% | 4157 |
|
|
2017
Q1 | $646K | Sell |
55,529
-75,739
| -58% | -$544K | ﹤0.01% | 4074 |
|
|
2016
Q4 | $611K | Buy |
131,268
+113,145
| +624% | +$664K | ﹤0.01% | 4059 |
|
|
2016
Q3 | $140K | Sell |
18,123
-252
| -1% | -$1.62K | ﹤0.01% | 4701 |
|
|
2016
Q2 | $111K | Sell |
18,375
-2,549
| -12% | -$20.7K | ﹤0.01% | 4764 |
|
|
2016
Q1 | $178K | Sell |
20,924
-337
| -2% | -$2.95K | ﹤0.01% | 4472 |
|
|
2015
Q4 | $254K | Buy |
21,261
+6,414
| +43% | +$81K | ﹤0.01% | 4306 |
|
|
2015
Q3 | $149K | Buy |
14,847
+3,947
| +36% | +$58.8K | ﹤0.01% | 4638 |
|
|
2015
Q2 | $181K | Buy |
10,900
+6,465
| +146% | +$102K | ﹤0.01% | 4666 |
|
|
2015
Q1 | $69K | Sell |
4,435
-1,122
| -20% | -$17K | ﹤0.01% | 4894 |
|
|
2014
Q4 | $88K | Buy |
5,557
+2,599
| +88% | +$33.8K | ﹤0.01% | 4790 |
|
|
2014
Q3 | $32K | Sell |
2,958
-591
| -17% | -$5.48K | ﹤0.01% | 5111 |
|
|
2014
Q2 | $34K | Buy |
3,549
+3,545
| +88,625% | +$22.7K | ﹤0.01% | 5119 |
|
|
2014
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 6069 |
|
|
2013
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 5921 |
|
|
2013
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5838 |
|
|
2013
Q2 | $0 | Buy |
+4
| New | +$26 | ﹤0.01% | 5697 |
|
Other funds holding TGTX
SCM
CAM
Wells Fargo's TGTX Position: Q2 2026 in Review
Wells Fargo increased its TG Therapeutics (TGTX) stake by 13% in Q2 2026, buying an estimated $1.77M and bringing the position to 375,894 shares worth $20.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1610.
Wells Fargo first reported a position in TGTX in Q2 2013 and has held it in 53 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Wells Fargo held 375,894 shares of TG Therapeutics worth $20.7M as of Q2 2026.
- Wells Fargo bought 43,174 TG Therapeutics shares in Q2 2026, an estimated $1.77M.
- TG Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1610 holding.
- Wells Fargo first reported a position in TG Therapeutics in Q2 2013 and has held it in 53 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.